S&P 500   3,339.32 (-1.01%)
DOW   28,940.59 (-0.96%)
QQQ   231.37 (-1.45%)
AAPL   316.99 (-1.03%)
FB   211.24 (-1.56%)
MSFT   180.48 (-2.14%)
GOOGL   1,500.52 (-1.09%)
AMZN   2,115.90 (-1.73%)
CGC   22.10 (-0.94%)
NVDA   298.47 (-3.31%)
BABA   213.74 (-1.97%)
MU   57.59 (-2.39%)
GE   12.37 (-1.28%)
TSLA   884.82 (-1.62%)
AMD   55.00 (-3.96%)
T   38.40 (-0.54%)
ACB   1.66 (-1.19%)
F   7.93 (-1.25%)
NFLX   382.61 (-0.88%)
PRI   133.66 (-2.02%)
BAC   34.39 (-1.32%)
DIS   139.27 (-0.78%)
S&P 500   3,339.32 (-1.01%)
DOW   28,940.59 (-0.96%)
QQQ   231.37 (-1.45%)
AAPL   316.99 (-1.03%)
FB   211.24 (-1.56%)
MSFT   180.48 (-2.14%)
GOOGL   1,500.52 (-1.09%)
AMZN   2,115.90 (-1.73%)
CGC   22.10 (-0.94%)
NVDA   298.47 (-3.31%)
BABA   213.74 (-1.97%)
MU   57.59 (-2.39%)
GE   12.37 (-1.28%)
TSLA   884.82 (-1.62%)
AMD   55.00 (-3.96%)
T   38.40 (-0.54%)
ACB   1.66 (-1.19%)
F   7.93 (-1.25%)
NFLX   382.61 (-0.88%)
PRI   133.66 (-2.02%)
BAC   34.39 (-1.32%)
DIS   139.27 (-0.78%)
S&P 500   3,339.32 (-1.01%)
DOW   28,940.59 (-0.96%)
QQQ   231.37 (-1.45%)
AAPL   316.99 (-1.03%)
FB   211.24 (-1.56%)
MSFT   180.48 (-2.14%)
GOOGL   1,500.52 (-1.09%)
AMZN   2,115.90 (-1.73%)
CGC   22.10 (-0.94%)
NVDA   298.47 (-3.31%)
BABA   213.74 (-1.97%)
MU   57.59 (-2.39%)
GE   12.37 (-1.28%)
TSLA   884.82 (-1.62%)
AMD   55.00 (-3.96%)
T   38.40 (-0.54%)
ACB   1.66 (-1.19%)
F   7.93 (-1.25%)
NFLX   382.61 (-0.88%)
PRI   133.66 (-2.02%)
BAC   34.39 (-1.32%)
DIS   139.27 (-0.78%)
S&P 500   3,339.32 (-1.01%)
DOW   28,940.59 (-0.96%)
QQQ   231.37 (-1.45%)
AAPL   316.99 (-1.03%)
FB   211.24 (-1.56%)
MSFT   180.48 (-2.14%)
GOOGL   1,500.52 (-1.09%)
AMZN   2,115.90 (-1.73%)
CGC   22.10 (-0.94%)
NVDA   298.47 (-3.31%)
BABA   213.74 (-1.97%)
MU   57.59 (-2.39%)
GE   12.37 (-1.28%)
TSLA   884.82 (-1.62%)
AMD   55.00 (-3.96%)
T   38.40 (-0.54%)
ACB   1.66 (-1.19%)
F   7.93 (-1.25%)
NFLX   382.61 (-0.88%)
PRI   133.66 (-2.02%)
BAC   34.39 (-1.32%)
DIS   139.27 (-0.78%)
Log in

NASDAQ:GNOM - Global X Genomics & Biotechnology ETF Stock Price, Forecast & News

$15.69
-0.14 (-0.88 %)
(As of 02/21/2020 10:17 AM ET)
Add
Today's Range
$15.67
Now: $15.69
$15.83
50-Day Range
$14.52
MA: $15.59
$16.32
52-Week Range
$11.88
Now: $15.69
$16.45
Volume307 shs
Average Volume6,847 shs
Market Capitalization$21.18 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A
Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:GNOM
CUSIPN/A
Phone+1-650-9432800

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$21.18 million
Next Earnings DateN/A
OptionableNot Optionable

Receive GNOM News and Ratings via Email

Sign-up to receive the latest news and ratings for GNOM and its competitors with MarketBeat's FREE daily newsletter.


Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Frequently Asked Questions

What is Global X Genomics & Biotechnology ETF's stock symbol?

Global X Genomics & Biotechnology ETF trades on the NASDAQ under the ticker symbol "GNOM."

Has Global X Genomics & Biotechnology ETF been receiving favorable news coverage?

News coverage about GNOM stock has been trending negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Global X Genomics & Biotechnology ETF earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Global X Genomics & Biotechnology ETF.

What other stocks do shareholders of Global X Genomics & Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global X Genomics & Biotechnology ETF investors own include Revance Therapeutics (RVNC), Evolus (EOLS), Genomic Health (GHDX), Merck & Co., Inc. (MRK), Caci International (CACI), AbbVie (ABBV), Juno Therapeutics (JUNO) and Editas Medicine (EDIT).

Who are Global X Genomics & Biotechnology ETF's major shareholders?

Global X Genomics & Biotechnology ETF's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Jane Street Group LLC (2.35%) and UBS Group AG (0.26%).

Which major investors are buying Global X Genomics & Biotechnology ETF stock?

GNOM stock was acquired by a variety of institutional investors in the last quarter, including Jane Street Group LLC and UBS Group AG.

How do I buy shares of Global X Genomics & Biotechnology ETF?

Shares of GNOM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Global X Genomics & Biotechnology ETF's stock price today?

One share of GNOM stock can currently be purchased for approximately $15.69.

How big of a company is Global X Genomics & Biotechnology ETF?

Global X Genomics & Biotechnology ETF has a market capitalization of $21.18 million. View Additional Information About Global X Genomics & Biotechnology ETF.

What is Global X Genomics & Biotechnology ETF's official website?

The official website for Global X Genomics & Biotechnology ETF is http://www.completegenomics.com/.

How can I contact Global X Genomics & Biotechnology ETF?

Global X Genomics & Biotechnology ETF's mailing address is 2071 Stierlin Ct, MOUNTAIN VIEW, CA 94043-4655, United States. The company can be reached via phone at +1-650-9432800.


MarketBeat Community Rating for Global X Genomics & Biotechnology ETF (NASDAQ GNOM)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  165 (Vote Outperform)
Underperform Votes:  163 (Vote Underperform)
Total Votes:  328
MarketBeat's community ratings are surveys of what our community members think about Global X Genomics & Biotechnology ETF and other stocks. Vote "Outperform" if you believe GNOM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNOM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Featured Article: What are no-load funds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel